Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia-reperfusion in vivo

Administration of nitric oxide (NO) donors during ischemia and reperfusion protects from myocardial injury. However, whether administration of an NO donor during a brief period prior to ischemia protects the myocardium and the endothelium against ischemia-reperfusion injury in vivo is unknown. To study this possibility anesthetized pigs were subjected to 45-min ligation of the left anterior descending coronary artery (LAD) followed by 4 It of reperfusion. In initial dose-finding experiments, vehicle or three different doses of the NO donor S-nitroso-N-acetyl-D,L-penicillamin (SNAP; 0.1; 0.5; 2.5 mumol) were infused into the LAD for 3 min starting 13 min during ischemia. Only the 0.5 mumol dose of SNAP reduced infarct size (from 85 +/- 3% of the area at risk in the vehicle group to 63 3% in the SNAP-treated group; p < 0.01). There were no significant differences in hemodynamics in the vehicle and SNAP groups during ischemia-reperfusion. Endothelium-dependent dilatation of coronary microvasculature induced by substance P was larger in the SNAP group than in the vehicle group. Myeloperoxidase activity was lower in the ischemic/reperfused myocardial area of pigs given SNAP (4.97 +/- 0.61 U/g) than in vehicle-treated pigs (8.45 +/- 0.25 U/g; p < 0.05). It is concluded that intracoronary administration of the NO donor SNAP for a brief period before ischemia reduces infarct size, attenuates neutrophil accumulation, and improves endothelial function. These results suggest that NO exerts a classic preconditioning-like protection against ischemia-reperfusion injury in vivo in a narrow concentration range. (C) 2002 Elsevier Science (USA). All rights reserved.